Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Bullboard Posts
Comment by Benedictuson Jul 11, 2019 10:10am
97 Views
Post# 29908386

RE:RE:when do i buy ?

RE:RE:when do i buy ?Khiron is severely oversold but let’s see if this 2 support region holds on a closing basis. I added again here. Next support zones are 1,75ish and 1.60ish. I’d be surprised if it gets to 1.60 but this sector rout continues to be vicious, so you just never know. Revenues should come on very strong next year but for now the market gets to play these games. I will say the timing of their placement at 2.90 was quite good as I see many others in the sector with high cash burn rates and needing to do a raise soon in this terrible pricing climate. Even though khiron has a high burn rate and even with a probable additional acquisition I do not see a need for a raise for 12 months or so. All imo
Bullboard Posts